HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Observations on intelligence and behavior in 15 patients with Legius syndrome.

Abstract
Legius syndrome is a RAS-MAPK syndrome characterized by pigmentary findings similar to neurofibromatosis type 1 (NF1), but without tumor complications. Learning difficulties and behavioral problems have been reported to be associated with Legius syndrome, but have not been studied systematically. We investigated intelligence and behavior in 15 patients with Legius syndrome and 7 unaffected family members. We report a mean full-scale IQ of 101.57 in patients with Legius syndrome, which does not differ from the control group. We find a significantly lower Performance IQ in children with Legius syndrome compared to their unaffected family members. Few behavioral problems are present as assessed by the Child Behavior Checklist (CBCL) questionnaire. Our observations suggest that, akin to the milder somatic phenotype, the cognitive phenotype in Legius syndrome is less severe than that of NF1.
AuthorsEllen Denayer, Mie-Jef Descheemaeker, Douglas R Stewart, Kathelijn Keymolen, Ellen Plasschaert, Sarah L Ruppert, Joseph Snow, Audrey E Thurm, Lisa A Joseph, Jean-Pierre Fryns, Eric Legius
JournalAmerican journal of medical genetics. Part C, Seminars in medical genetics (Am J Med Genet C Semin Med Genet) Vol. 157C Issue 2 Pg. 123-8 (May 15 2011) ISSN: 1552-4876 [Electronic] United States
PMID21495177 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright2011 Wiley-Liss, Inc.
Topics
  • Adolescent
  • Behavioral Symptoms (physiopathology)
  • Belgium
  • Cafe-au-Lait Spots (physiopathology)
  • Child
  • Child, Preschool
  • Cognition Disorders (physiopathology)
  • Female
  • Humans
  • Intelligence (physiology)
  • Intelligence Tests
  • Male
  • Statistics, Nonparametric
  • Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: